Fique off-line com o app Player FM !
Episode #299 - Exciting Developments in Drug Delivery with Lifescient - Kamalesh Rao and Renee Sera
Manage episode 441771565 series 2551977
Kamalesh Rao is the founder and CEO of Lifescient. Lifescient was established by Kamalesh, who has twenty-five years of experience in Pharmaceutical development. He played a pivotal role in the team that successfully created a sustained-release injectable to alleviate symptoms of opioid withdrawal in humans. Renee Sera is the Chief Administrative Officer and one of the founding investors of Lifescient. She is a small business owner, real estate developer, and an angel investor.
Learn more about Lifescient at https://lifescient.com/
Support Lifescient's crowdfunding campaign at: https://wefunder.com/lifescient
Follow on LinkedIn: https://www.linkedin.com/company/lifescient-inc
Contact with comments or questions: [email protected]
Contact Julie at [email protected]
322 episódios
Manage episode 441771565 series 2551977
Kamalesh Rao is the founder and CEO of Lifescient. Lifescient was established by Kamalesh, who has twenty-five years of experience in Pharmaceutical development. He played a pivotal role in the team that successfully created a sustained-release injectable to alleviate symptoms of opioid withdrawal in humans. Renee Sera is the Chief Administrative Officer and one of the founding investors of Lifescient. She is a small business owner, real estate developer, and an angel investor.
Learn more about Lifescient at https://lifescient.com/
Support Lifescient's crowdfunding campaign at: https://wefunder.com/lifescient
Follow on LinkedIn: https://www.linkedin.com/company/lifescient-inc
Contact with comments or questions: [email protected]
Contact Julie at [email protected]
322 episódios
Todos os episódios
×Bem vindo ao Player FM!
O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.